Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 6:45 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1345–1368 of 1,740 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Study Device Arm Clear all

Conditions: Chronic Low Back Pain
Interventions: Distraction-Based VR, Sham VR, Skills-Based VR, Activity Tracker; Device
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 13 Years and older
Enrollment: 413 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Smoking Cessation, Smoking, Nicotine Dependence
Interventions: Nicotine patch, Cessation Counseling, Mobile Games; Drug · Behavioral · Device
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Shoulder Pain Chronic
Interventions: Battery Powered Microneuromodulator (BBPM); Device
Lead sponsor: Bioness Inc; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 3
States / cities: Downey, California • Seattle, Washington • Charleston, West Virginia

Conditions: Intraosseous Vascular Access, Vascular Access
Interventions: Intraosseous Vascular Access; Device
Lead sponsor: Vidacare Corporation; Industry
Eligibility: 21 Years and older
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 1
States / cities: Spring Branch, Texas

Conditions: Incomplete Spinal Cord Injury, Muscular Dystrophy, Spina Bifida, Cerebral Palsy
Interventions: EA-KAFO; Device
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: 5 Years to 100 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2025
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Heart Failure, Ventricular Dysfunction
Interventions: CoSeal, BioGlue® Surgical Adhesive; Device
Lead sponsor: The Methodist Hospital Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 2
States / cities: Houston, Texas

Conditions: Female Sexual Dysfunction, Female Sexual Dysfunction Due to Physical Condition
Interventions: Transcutaneous electrical nerve stimulation - Tibial Nerve, Transcutaneous electrical nerve stimulation - Genital Nerve, Neutral and Erotic Film Clip Alternation; Device · Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older · Female only
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Heart Failure
Interventions: V-Wave Interatrial Shunt, Control; Device · Other
Lead sponsor: V-Wave Ltd; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 605 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2027
U.S. locations: 43
States / cities: Phoenix, Arizona • La Jolla, California • Long Beach, California + 35 more

Conditions: RDS of Prematurity, Preterm Birth, Lung Diseases
Interventions: Lung monitoring with the Neola device; Device
Lead sponsor: Neola Medical Inc; Industry
Eligibility: 1 Day to 44 Weeks
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Palo Alto, California • Camden, New Jersey

Conditions: Chronic Heart Failure
Interventions: BAY2413555 Dose 1, BAY2413555 Dose 2, Placebo to BAY2413555; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years to 79 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 3
States / cities: Atlanta, Georgia • Silver Spring, Maryland • Camp Hill, Pennsylvania

Conditions: Neurological Disorder, ALS (Amyotrophic Lateral Sclerosis), Motor Neuron Disease, ALS - Amyotrophic Lateral Sclerosis, ALS
Interventions: Stentrode; Device
Lead sponsor: Synchron, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 5
States / cities: Jacksonville, Florida • Buffalo, New York • New York, New York + 2 more

Conditions: Mild Cognitive Impairment, Cognitive Impairment
Interventions: 20 IU Humulin® R U-100 (NDC: 0002-8215, Eli Lilly & Company), 40 IU Humulin® R U-100 (NDC: 0002-8215, Eli Lilly & Company); Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 55 Years to 85 Years
Enrollment: 13 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Aortic Stenosis
Interventions: ACURATE neo2™ Transfemoral TAVR System, Medtronic CoreValve TAVR System, Edwards SAPIEN 3 TAVR System, ACURATE Prime™ Transfemoral TAVR System XL; Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: Not listed
Enrollment: 1,948 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2029
U.S. locations: 69
States / cities: Birmingham, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 58 more

Conditions: Chemotherapy-induced Peripheral Neuropathy
Interventions: Electroacupuncture, NeuroMetrix, Rydel-Seiffer tuning fork; Device
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Toileting in Adults With Impaired Functional Status, Caregiver Burden for Those Who Care for Adults With Impaired Functional Status, UTI in Adults With Impaired Functional Status
Interventions: Bidet use, Regular toileting; Behavioral · Other
Lead sponsor: Stanford University; Other
Eligibility: 21 Years to 95 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Stanford, California

Conditions: Microtia, Congenital, Microtia, Microtia-Anotia, Ear Deformities, Acquired, Ear Deformity External, Ear Malformation, Ear Cartilage
Interventions: Use of AuryzoN™ EAR 2.0 device, Hand carving; Procedure
Lead sponsor: Nemours Children's Clinic; Other
Eligibility: 5 Years to 20 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Heart Failure
Interventions: Inter-Atrial Shunt Device, Intracardiac Echo; Device · Other
Lead sponsor: Corvia Medical; Industry
Eligibility: 40 Years and older
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2026
U.S. locations: 17
States / cities: Tucson, Arizona • New Haven, Connecticut • Chicago, Illinois + 11 more

Conditions: Femoro Acetabular Impingement
Interventions: LoopLoc Arm, Control Arm; Device
Lead sponsor: American Hip Institute; Other
Eligibility: 18 Years to 60 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Des Plaines, Illinois

Conditions: Diabetes, Hypertension, Cardiac Arrhythmia
Interventions: DM Pgm + device, Control; Device · Behavioral
Lead sponsor: Scripps Translational Science Institute; Other
Eligibility: 18 Years and older
Enrollment: 182 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Chronic Migraine
Interventions: Nerivio; Device
Lead sponsor: Theranica; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Lagrangeville, New York

Conditions: Cardiac Pacemaker, Arrythmia, Bradycardia
Interventions: Aveir VR Leadless Pacemaker System; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 3,427 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2034
U.S. locations: 1
States / cities: Sylmar, California

Conditions: Major Depressive Disorder
Interventions: Fisher Wallace Cranial Electrotherapy Stimulator Device; Device
Lead sponsor: ProofPilot; Industry
Eligibility: 21 Years and older
Enrollment: 175 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Amputation, Amputation, Traumatic, Amputation of Knee, Amputation; Traumatic, Limb
Interventions: Ottobock CLeg4 + Ottobock foot, SRALAB Hybrid Knee + Polycentric Ankle, SRALAB Hybrid Knee + Passive Ankle, Ottobock CLeg 4 + Polycentric Ankle; Device
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 18 Years to 95 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Nodular Basal Cell Carcinoma
Interventions: D-MNA 200µg, D-MNA 100µg, Microneedle Array Alone; Drug · Other
Lead sponsor: SkinJect, Inc.; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 10
States / cities: Fresno, California • San Diego, California • Naperville, Illinois + 6 more

Search by objective public record fields.

Virtual Reality Therapy for Chronic Low Back Pain

A Quit Smoking Study Using Smartphones

An Implantable Microneuromodulator for the Treatment of Chronic Shoulder Pain in Chronic Post-Stroke Subjects

Follow-Up Study Validating a Blended Technique to Identify the Proximal Humerus Intraosseous Vascular Access Site

Evaluating a New Knee-Ankle-Foot Brace to Improve Gait in Children With Movement Disorders

The Use of CoSeal (Sealant Agent) in Patients During Left Ventricular Assist Device Surgery

Effect of Peripheral Neuromodulation on Vaginal Blood Flow - Study 2

Reducing Lung CongestIon Symptoms in Advanced Heart Failure

Pivotal Study to Assess Safety and Performance of Neola®, a Novel Lung Monitoring Device for Neonates

A Study to Learn How Safe Study Drug BAY2413555 is, How it Affects the Body, and How it Moves Into, Through, and Out of the Body Over 4 Weeks of Use in Participants With Heart Failure and Implanted Cardiac Defibrillator or Cardiac Resynchronization Devices (ICD/CRT)

INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study

SNIFF Multi-Device Study 2

ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement

Feasibility Study for Electroacupuncture for Chemotherapy- Induced Peripheral Neuropathy (CIPN)

Quality of Life in Adults Impaired Functioning - A Randomized Controlled Trial of Bidet vs Usual Toileting

Evaluation of the Auryzon™ EAR 2.0 System in Ear Reconstruction

REDUCE LAP-HF RANDOMIZED TRIAL I

Knotless Implants As an Alternative for Capsular Closure in Primary Hip Arthroscopy: a Prospective, Multi-Center Study

Scripps Wired for Health Monitoring Study

Efficacy and Safety of Nerivio™ for Acute Treatment of Migraine in People With Chronic Migraine

Aveir VR Real-World Evidence Post-Approval Study

Fisher Wallace Neurostimulation & Depression Study

Understanding How Powered Componentry Impacts K2-Level Transfemoral Amputee Gait

Phase 2 Study Evaluating the Safety and Efficacy of Microneedle-mediated Delivery of Doxorubicin (D-MNA) in Patients With Nodular Basal Cell Carcinoma.